Tapewire

Nasdaq · USD

CYTK

CYTOKINETICS INC

Export transactions ↓
Tapewire entity
3528
SEC CIK
0001061983
Parsed reports
875

Last 12 months

Inside the activity.

0 purchase rows · 83 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202504
Dec 202509
Jan 202603
Feb 202602
Mar 2026017
Apr 202608
May 202609
Jun 202608
Jul 202609
Aug 202604
Sep 202608
Oct 202602

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 10, 2023 Filed May 18, 2023 20:33 UTC
Bhanji MunaDirector
GrantNon-Qualified Stock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $37.89 $0.00
Disclosure

SEC source: 0001127602-23-016157 · form4.xml · derivative · entry 2

Bhanji Muna · CIK 0001846905 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2033-05-10

F2 · kind: Options shall vest and become exercisable in 12 equal monthly installments, the first such installment vesting on 06/10/2023 and the last such installment vesting on 05/10/2024.

Read SEC document
May 10, 2023 Filed May 18, 2023 20:33 UTC
Bhanji MunaDirector
GrantCommon Stock 5,000 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-016157 · form4.xml · nonDerivative · entry 1

Bhanji Muna · CIK 0001846905 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,031

F1 · kind: Comprised of restricted stock units that will vest in full and in one installment on 05/10/2024.

Read SEC document
May 03, 2023 Filed May 3, 2023 20:46 UTC
Malik Fady IbrahamEVP Research & Development
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative 7,000 $0.00 Strike: $7.96 $0.00
Disclosure

SEC source: 0001127602-23-014289 · form4.xml · derivative · entry 3

Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 74,322

Underlying: Common Stock · 7,000 shares

Expires 2025-02-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 20, 2022.

Read SEC document
May 03, 2023 Filed May 3, 2023 20:46 UTC
Malik Fady IbrahamEVP Research & Development
SaleCommon Stock 7,000 $40.00 $280,000.00
Disclosure

SEC source: 0001127602-23-014289 · form4.xml · nonDerivative · entry 2

Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 167,183

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 20, 2022.

Read SEC document
May 03, 2023 Filed May 3, 2023 20:46 UTC
Malik Fady IbrahamEVP Research & Development
Exercise / conversionCommon Stock 7,000 $7.96 $55,720.00
Disclosure

SEC source: 0001127602-23-014289 · form4.xml · nonDerivative · entry 1

Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 174,183

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 20, 2022.

Read SEC document
April 28, 2023 Filed Apr 28, 2023 20:01 UTC
Blum Robert IDirector · President & CEO
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative 12,500 $0.00 Strike: $9.65 $0.00
Disclosure

SEC source: 0001127602-23-013772 · form4.xml · derivative · entry 5

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 83,191

Underlying: Common Stock · 12,500 shares

Expires 2024-02-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 27, 2022.

Read SEC document
April 28, 2023 Filed Apr 28, 2023 20:01 UTC
Blum Robert IDirector · President & CEO
SaleCommon Stock 12,500 $37.68 $471,000.00
Disclosure

SEC source: 0001127602-23-013772 · form4.xml · nonDerivative · entry 4

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 441,058

F3 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 27, 2022.

Read SEC document
April 28, 2023 Filed Apr 28, 2023 20:01 UTC
Blum Robert IDirector · President & CEO
Exercise / conversionCommon Stock 12,500 $9.65 $120,625.00
Disclosure

SEC source: 0001127602-23-013772 · form4.xml · nonDerivative · entry 3

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 453,558

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 27, 2022.

Read SEC document
April 14, 2023 Filed Apr 14, 2023 22:34 UTC
Blum Robert IDirector · President & CEO
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative 12,500 $0.00 Strike: $9.65 $0.00
Disclosure

SEC source: 0001127602-23-012942 · form4.xml · derivative · entry 5

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 95,691

Underlying: Common Stock · 12,500 shares

Expires 2024-02-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 27, 2022.

Read SEC document
April 14, 2023 Filed Apr 14, 2023 22:34 UTC
Blum Robert IDirector · President & CEO
SaleCommon Stock 12,500 $35.61 $445,125.00
Disclosure

SEC source: 0001127602-23-012942 · form4.xml · nonDerivative · entry 4

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 441,058

F3 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 27, 2022.

Read SEC document
April 14, 2023 Filed Apr 14, 2023 22:34 UTC
Blum Robert IDirector · President & CEO
Exercise / conversionCommon Stock 12,500 $9.65 $120,625.00
Disclosure

SEC source: 0001127602-23-012942 · form4.xml · nonDerivative · entry 3

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 453,558

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 27, 2022.

Read SEC document
April 13, 2023 Filed Apr 13, 2023 20:49 UTC
Malik Fady IbrahamEVP Research & Development
SaleCommon Stock 4,000 $34.21 $136,840.00
Disclosure

SEC source: 0001127602-23-012887 · form4.xml · nonDerivative · entry 1

Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 167,183

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021.

Read SEC document
April 03, 2023 Filed Apr 5, 2023 20:13 UTC GrantCommon Stock 298 $37.71 $11,237.58
Disclosure

SEC source: 0001127602-23-012559 · form4.xml · nonDerivative · entry 1

Harrington Robert Arthur · CIK 0001923988 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,551

F1 · kind: Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of director's annual base retainer program. Shares are fully vested from the moment of grant. Shares are issued at per share price of $37.71, representing the closing stock price of the Issuer's common stock on April 3, 2023.

Read SEC document
April 03, 2023 Filed Apr 5, 2023 20:09 UTC GrantCommon Stock 530 $37.71 $19,986.30
Disclosure

SEC source: 0001127602-23-012552 · form4.xml · nonDerivative · entry 1

HENDERSON JOHN T · CIK 0001226488 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,420

F1 · kind: Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of director's annual base retainer program. Shares are fully vested from the moment of grant. Shares are issued at per share price of $37.71, representing the closing stock price of the Issuer's common stock on April 3, 2023.

Read SEC document
April 03, 2023 Filed Apr 5, 2023 20:08 UTC GrantCommon Stock 298 $37.71 $11,237.58
Disclosure

SEC source: 0001127602-23-012548 · form4.xml · nonDerivative · entry 1

Kaye Edward M. MD · CIK 0001522780 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,347

F1 · kind: Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of director's annual base retainer program. Shares are fully vested from the moment of grant. Shares are issued at per share price of $37.71, representing the closing stock price of the Issuer's common stock on April 3, 2023.

Read SEC document
April 03, 2023 Filed Apr 5, 2023 20:06 UTC GrantCommon Stock 298 $37.71 $11,237.58
Disclosure

SEC source: 0001127602-23-012545 · form4.xml · nonDerivative · entry 1

SMITH SANDFORD D · CIK 0001243004 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,831

F1 · kind: Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of director's annual base retainer program. Shares are fully vested from the moment of grant. Shares are issued at per share price of $37.71, representing the closing stock price of the Issuer's common stock on April 3, 2023.

Read SEC document
April 03, 2023 Filed Apr 5, 2023 20:04 UTC GrantCommon Stock 298 $37.71 $11,237.58
Disclosure

SEC source: 0001127602-23-012541 · form4.xml · nonDerivative · entry 1

WIERENGA WENDALL · CIK 0001235945 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,831

F1 · kind: Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of director's annual base retainer program. Shares are fully vested from the moment of grant. Shares are issued at per share price of $37.71, representing the closing stock price of the Issuer's common stock on April 3, 2023.

Read SEC document
April 03, 2023 Filed Apr 5, 2023 20:02 UTC GrantCommon Stock 149 $37.71 $5,618.79
Disclosure

SEC source: 0001127602-23-012536 · form4.xml · nonDerivative · entry 1

Wysenski Nancy · CIK 0001294596 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,671

F1 · kind: Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of director's annual base retainer program. Shares are fully vested from the moment of grant. Shares are issued at per share price of $37.71, representing the closing stock price of the Issuer's common stock on April 3, 2023.

Read SEC document
March 28, 2023 Filed Mar 28, 2023 21:25 UTC
Blum Robert IDirector · President & CEO
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative 12,500 $0.00 Strike: $9.65 $0.00
Disclosure

SEC source: 0001127602-23-011519 · form4.xml · derivative · entry 5

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 108,191

Underlying: Common Stock · 12,500 shares

Expires 2024-02-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 27, 2022.

Read SEC document
March 28, 2023 Filed Mar 28, 2023 21:25 UTC
Blum Robert IDirector · President & CEO
SaleCommon Stock 12,500 $35.05 $438,125.00
Disclosure

SEC source: 0001127602-23-011519 · form4.xml · nonDerivative · entry 4

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 441,058

F3 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 27, 2022.

Read SEC document
March 28, 2023 Filed Mar 28, 2023 21:25 UTC
Blum Robert IDirector · President & CEO
Exercise / conversionCommon Stock 12,500 $9.65 $120,625.00
Disclosure

SEC source: 0001127602-23-011519 · form4.xml · nonDerivative · entry 3

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 453,558

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 27, 2022.

Read SEC document
March 15, 2023 Filed Mar 17, 2023 20:00 UTC
Blum Robert IDirector · President & CEO
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative 12,500 $0.00 Strike: $9.65 $0.00
Disclosure

SEC source: 0001127602-23-010630 · form4.xml · derivative · entry 5

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,691

Underlying: Common Stock · 12,500 shares

Expires 2024-02-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 27, 2022.

Read SEC document
March 15, 2023 Filed Mar 17, 2023 20:00 UTC
Blum Robert IDirector · President & CEO
SaleCommon Stock 12,500 $37.26 $465,750.00
Disclosure

SEC source: 0001127602-23-010630 · form4.xml · nonDerivative · entry 4

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 441,058

F3 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 27, 2022.

Read SEC document
March 15, 2023 Filed Mar 17, 2023 20:00 UTC
Blum Robert IDirector · President & CEO
Exercise / conversionCommon Stock 12,500 $9.65 $120,625.00
Disclosure

SEC source: 0001127602-23-010630 · form4.xml · nonDerivative · entry 3

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 453,558

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 27, 2022.

Read SEC document
March 09, 2023 Filed Mar 9, 2023 22:09 UTC
Malik Fady IbrahamEVP Research & Development
SaleCommon Stock 4,000 $39.10 $156,400.00
Disclosure

SEC source: 0001127602-23-009590 · form4.xml · nonDerivative · entry 1

Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 171,183

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021.

Read SEC document
March 06, 2023 Filed Mar 7, 2023 21:19 UTC
Wong RobertVP, Chief Accounting Officer
GrantNon-Qualified Stock Option (Right to Buy) · Derivative 9,536 $0.00 Strike: $39.13 $0.00
Disclosure

SEC source: 0001127602-23-009290 · form4.xml · derivative · entry 3

Wong Robert · CIK 0001777562 · VP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,536

Underlying: Common Stock · 9,536 shares

Expires 2033-03-06

F2 · kind: This option shall vest and become exercisable in equal monthly installments over 4 years commencing on April 6, 2023, with the final installment vesting on April 6, 2027.

Read SEC document
March 06, 2023 Filed Mar 7, 2023 21:19 UTC
Wong RobertVP, Chief Accounting Officer
GrantIncentive Stock Option (Right to Buy) · Derivative 2,464 $0.00 Strike: $39.13 $0.00
Disclosure

SEC source: 0001127602-23-009290 · form4.xml · derivative · entry 2

Wong Robert · CIK 0001777562 · VP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,464

Underlying: Common Stock · 2,464 shares

Expires 2033-03-06

F2 · kind: This option shall vest and become exercisable in equal monthly installments over 4 years commencing on April 6, 2023, with the final installment vesting on April 6, 2027.

Read SEC document
March 06, 2023 Filed Mar 7, 2023 21:19 UTC
Wong RobertVP, Chief Accounting Officer
GrantCommon Stock 6,000 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-009290 · form4.xml · nonDerivative · entry 1

Wong Robert · CIK 0001777562 · VP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,613

F1 · kind: Award comprised of Restricted Stock Units that will vest over 3-years, with 40% vesting on the 1-year anniversary of the date of grant, an additional 40% vesting on the 2-year anniversary of the date of grant, and the remaining 20% vesting on the 3-year anniversary of the date of grant.

Read SEC document
March 06, 2023 Filed Mar 7, 2023 21:17 UTC
Malik Fady IbrahamEVP Research & Development
GrantNon-Qualified Stock Option (Right to Buy) · Derivative 77,445 $0.00 Strike: $39.13 $0.00
Disclosure

SEC source: 0001127602-23-009288 · form4.xml · derivative · entry 3

Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,445

Underlying: Common Stock · 77,445 shares

Expires 2033-03-06

F2 · kind: This option shall vest and become exercisable in equal monthly installments over 4 years commencing on April 6, 2023, with the final installment vesting on April 6, 2027.

Read SEC document
March 06, 2023 Filed Mar 7, 2023 21:17 UTC
Malik Fady IbrahamEVP Research & Development
GrantIncentive Stock Option (Right to Buy) · Derivative 2,555 $0.00 Strike: $39.13 $0.00
Disclosure

SEC source: 0001127602-23-009288 · form4.xml · derivative · entry 2

Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,555

Underlying: Common Stock · 2,555 shares

Expires 2033-03-06

F2 · kind: This option shall vest and become exercisable in equal monthly installments over 4 years commencing on April 6, 2023, with the final installment vesting on April 6, 2027.

Read SEC document
March 06, 2023 Filed Mar 7, 2023 21:17 UTC
Malik Fady IbrahamEVP Research & Development
GrantCommon Stock 40,000 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-009288 · form4.xml · nonDerivative · entry 1

Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 175,183

F1 · kind: Award comprised of Restricted Stock Units that will vest over 3-years, with 40% vesting on the 1-year anniversary of the date of grant, an additional 40% vesting on the 2-year anniversary of the date of grant, and the remaining 20% vesting on the 3-year anniversary of the date of grant.

Read SEC document
March 06, 2023 Filed Mar 7, 2023 21:15 UTC
Jaw ChingSVP Finance & CFO
GrantNon-Qualified Stock Option (Right to Buy) · Derivative 47,445 $0.00 Strike: $39.13 $0.00
Disclosure

SEC source: 0001127602-23-009285 · form4.xml · derivative · entry 3

Jaw Ching · CIK 0001710875 · SVP Finance & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,445

Underlying: Common Stock · 47,445 shares

Expires 2033-03-06

F2 · kind: This option shall vest and become exercisable in equal monthly installments over 4 years commencing on April 6, 2023, with the final installment vesting on April 6, 2027.

Read SEC document
March 06, 2023 Filed Mar 7, 2023 21:15 UTC
Jaw ChingSVP Finance & CFO
GrantIncentive Stock Option (Right to Buy) · Derivative 2,555 $0.00 Strike: $39.13 $0.00
Disclosure

SEC source: 0001127602-23-009285 · form4.xml · derivative · entry 2

Jaw Ching · CIK 0001710875 · SVP Finance & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,555

Underlying: Common Stock · 2,555 shares

Expires 2033-03-06

F2 · kind: This option shall vest and become exercisable in equal monthly installments over 4 years commencing on April 6, 2023, with the final installment vesting on April 6, 2027.

Read SEC document
March 06, 2023 Filed Mar 7, 2023 21:15 UTC
Jaw ChingSVP Finance & CFO
GrantCommon Stock 30,000 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-009285 · form4.xml · nonDerivative · entry 1

Jaw Ching · CIK 0001710875 · SVP Finance & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,346

F1 · kind: Award comprised of Restricted Stock Units that will vest over 3-years, with 40% vesting on the 1-year anniversary of the date of grant, an additional 40% vesting on the 2-year anniversary of the date of grant, and the remaining 20% vesting on the 3-year anniversary of the date of grant.

Read SEC document
March 06, 2023 Filed Mar 7, 2023 21:13 UTC
Callos AndrewEVP, Chief Commercial Officer
GrantNon-Qualified Stock Option (Right to Buy) · Derivative 47,445 $0.00 Strike: $39.13 $0.00
Disclosure

SEC source: 0001127602-23-009282 · form4.xml · derivative · entry 3

Callos Andrew · CIK 0001852129 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,445

Underlying: Common Stock · 47,445 shares

Expires 2033-03-06

F2 · kind: This option shall vest and become exercisable in equal monthly installments over 4 years commencing on April 6, 2023, with the final installment vesting on April 6, 2027.

Read SEC document
March 06, 2023 Filed Mar 7, 2023 21:13 UTC
Callos AndrewEVP, Chief Commercial Officer
GrantIncentive Stock Option (Right to Buy) · Derivative 2,555 $0.00 Strike: $39.13 $0.00
Disclosure

SEC source: 0001127602-23-009282 · form4.xml · derivative · entry 2

Callos Andrew · CIK 0001852129 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,555

Underlying: Common Stock · 2,555 shares

Expires 2033-03-06

F2 · kind: This option shall vest and become exercisable in equal monthly installments over 4 years commencing on April 6, 2023, with the final installment vesting on April 6, 2027.

Read SEC document
March 06, 2023 Filed Mar 7, 2023 21:13 UTC
Callos AndrewEVP, Chief Commercial Officer
GrantCommon Stock 30,000 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-009282 · form4.xml · nonDerivative · entry 1

Callos Andrew · CIK 0001852129 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,683

F1 · kind: Award comprised of Restricted Stock Units that will vest over 3-years, with 40% vesting on the 1-year anniversary of the date of grant, an additional 40% vesting on the 2-year anniversary of the date of grant, and the remaining 20% vesting on the 3-year anniversary of the date of grant.

Read SEC document
March 06, 2023 Filed Mar 7, 2023 21:11 UTC
Blum Robert IDirector · President & CEO
GrantNon-Qualified Stock Option (Right to Buy) · Derivative 162,445 $0.00 Strike: $39.13 $0.00
Disclosure

SEC source: 0001127602-23-009279 · form4.xml · derivative · entry 5

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 162,445

Underlying: Common Stock · 162,445 shares

Expires 2033-03-06

F4 · kind: This option shall vest and become exercisable over 4-years, with vesting divided into equal monthly installments commencing on April 6, 2023 and the final monthly installment vesting on April 6, 2027.

Read SEC document
March 06, 2023 Filed Mar 7, 2023 21:11 UTC
Blum Robert IDirector · President & CEO
GrantIncentive Stock Option (Right to Buy) · Derivative 2,555 $0.00 Strike: $39.13 $0.00
Disclosure

SEC source: 0001127602-23-009279 · form4.xml · derivative · entry 4

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,555

Underlying: Common Stock · 2,555 shares

Expires 2033-03-06

F4 · kind: This option shall vest and become exercisable over 4-years, with vesting divided into equal monthly installments commencing on April 6, 2023 and the final monthly installment vesting on April 6, 2027.

Read SEC document
March 06, 2023 Filed Mar 7, 2023 21:11 UTC
Blum Robert IDirector · President & CEO
GrantCommon Stock 82,500 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-009279 · form4.xml · nonDerivative · entry 1

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 441,058

F1 · kind: Award comprised of Restricted Stock Units that will vest over 3-years, with 40% vesting on the 1-year anniversary of the date of grant, an addiitional 40% vesting on the 2-year anniversary of the date of grant, and the remaining 20% vesting on the 3-year anniversary of the date of grant.

Read SEC document
March 06, 2023 Filed Mar 7, 2023 21:09 UTC
Wong RobertVP, Chief Accounting Officer
Tax withholdingCommon Stock 692 $39.13 $27,077.96
Disclosure

SEC source: 0001127602-23-009274 · form4.xml · nonDerivative · entry 1

Wong Robert · CIK 0001777562 · VP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,613

F1 · kind: The reporting person is reporting the withholding of shares of common stock to satisfy the reporting persons withholding obligations in connection with the vesting of Restricted Stock Units vested on March 6, 2023 and does not represent a sale by the reporting person.

Read SEC document
March 06, 2023 Filed Mar 7, 2023 21:07 UTC
Malik Fady IbrahamEVP Research & Development
Tax withholdingCommon Stock 4,958 $39.13 $194,006.54
Disclosure

SEC source: 0001127602-23-009271 · form4.xml · nonDerivative · entry 1

Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 135,183

F1 · kind: The reporting person is reporting the withholding of shares of common stock to satisfy the reporting persons withholding obligations in connection with the vesting of Restricted Stock Units vested on March 6, 2023 and does not represent a sale by the reporting person.

Read SEC document
March 06, 2023 Filed Mar 7, 2023 21:05 UTC
Jaw ChingSVP Finance & CFO
Tax withholdingCommon Stock 2,403 $39.13 $94,029.39
Disclosure

SEC source: 0001127602-23-009266 · form4.xml · nonDerivative · entry 1

Jaw Ching · CIK 0001710875 · SVP Finance & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,346

F1 · kind: The reporting person is reporting the withholding of shares of common stock to satisfy the reporting persons withholding obligations in connection with the vesting of Restricted Stock Units vested on March 6, 2023, and does not represent a sale by the reporting person.

Read SEC document
March 06, 2023 Filed Mar 7, 2023 21:03 UTC
Blum Robert IDirector · President & CEO
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative 12,500 $0.00 Strike: $9.65 $0.00
Disclosure

SEC source: 0001127602-23-009262 · form4.xml · derivative · entry 6

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 133,191

Underlying: Common Stock · 12,500 shares

Expires 2024-02-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 27, 2022.

Read SEC document
March 06, 2023 Filed Mar 7, 2023 21:03 UTC
Blum Robert IDirector · President & CEO
Tax withholdingCommon Stock 11,900 $39.13 $465,647.00
Disclosure

SEC source: 0001127602-23-009262 · form4.xml · nonDerivative · entry 5

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 358,558

F4 · kind: The reporting person is reporting the withholding of shares of common stock to satisfy the reporting persons withholding obligations in connection with the vesting of Restricted Stock Units vested on March 6, 2023 and does not represent a sale by the reporting person.

Read SEC document
March 06, 2023 Filed Mar 7, 2023 21:03 UTC
Blum Robert IDirector · President & CEO
SaleCommon Stock 12,500 $39.94 $499,250.00
Disclosure

SEC source: 0001127602-23-009262 · form4.xml · nonDerivative · entry 4

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 370,458

F3 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 27, 2022.

Read SEC document
March 06, 2023 Filed Mar 7, 2023 21:03 UTC
Blum Robert IDirector · President & CEO
Exercise / conversionCommon Stock 12,500 $9.65 $120,625.00
Disclosure

SEC source: 0001127602-23-009262 · form4.xml · nonDerivative · entry 3

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 382,958

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 27, 2022.

Read SEC document
March 02, 2023 Filed Mar 3, 2023 23:20 UTC
Wong RobertVP, Chief Accounting Officer
Tax withholdingCommon Stock 2,484 $39.60 $98,366.40
Disclosure

SEC source: 0001127602-23-008873 · form4.xml · nonDerivative · entry 1

Wong Robert · CIK 0001777562 · VP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,305

F1 · kind: The reporting person is reporting the withholding of shares of common stock to satisfy the reporting persons withholding obligations in connection with the vesting of Restricted Stock Units vested on March 2, 2023 and does not represent a sale by the reporting person.

Read SEC document
March 02, 2023 Filed Mar 3, 2023 23:16 UTC
Malik Fady IbrahamEVP Research & Development
Tax withholdingCommon Stock 10,785 $39.60 $427,086.00
Disclosure

SEC source: 0001127602-23-008868 · form4.xml · nonDerivative · entry 1

Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 140,141

F1 · kind: The reporting person is reporting the withholding of shares of common stock to satisfy the reporting persons withholding obligations in connection with the vesting of Restricted Stock Units vested on March 2, 2023 and does not represent a sale by the reporting person.

Read SEC document
March 02, 2023 Filed Mar 3, 2023 23:13 UTC
Jaw ChingSVP Finance & CFO
Tax withholdingCommon Stock 6,225 $39.60 $246,510.00
Disclosure

SEC source: 0001127602-23-008861 · form4.xml · nonDerivative · entry 1

Jaw Ching · CIK 0001710875 · SVP Finance & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,749

F1 · kind: The reporting person is reporting the withholding of shares of common stock to satisfy the reporting persons withholding obligations in connection with the vesting of Restricted Stock Units vested on March 2, 2023, and does not represent a sale by the reporting person.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.